ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

UNC Lineberger Center Recruits Richard Goldberg From Mayo

April 11, 2003

FDA Proposes To Require Electronic Submission

May 3, 2002

Ovariectomy Without HRT Increases Death Rate

September 29, 2006

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005